Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             57 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgements 1997
 2S1 p. S4-
1 p.
 artikel
2 Acronyms and Abbreviations 2002
 2S1 p. S7-S10
4 p.
 artikel
3 Analytical methods 1999
 2S1 p. S152-S176
25 p.
 artikel
4 Annual facility survey of providers of ESRD therapy 1999
 2S1 p. S140-S143
4 p.
 artikel
5 Bibliography 2002
 2S1 p. S246-S266
21 p.
 artikel
6 Causes of death 1999
 2S1 p. S87-S94
8 p.
 artikel
7 Editorial Board 2002
 2S1 p. IFC-
1 p.
 artikel
8 Evidence-based recommendations for the clinical use of recombinant human erythropoietin Muirhead, Norman
 1995
 2S1 p. S1-S24
24 p.
 artikel
9 Executive summary 1997
 2S1 p. S10-S20
11 p.
 artikel
10 Executive summary 1999
 2S1 p. S9-S19
11 p.
 artikel
11 Figures 2002
 2S1 p. S5-S6
2 p.
 artikel
12 Foreword 2002
 2S1 p. S14-S16
3 p.
 artikel
13 Hospitalization 1999
 2S1 p. S114-S123
10 p.
 artikel
14 II. Incidence and prevalence of ESRD 1997
 2S1 p. S40-S53
14 p.
 artikel
15 III. Treatment modalities for ESRD patients 1997
 2S1 p. S54-S66
13 p.
 artikel
16 Incidence and prevalence of ESRD 1999
 2S1 p. S40-S50
11 p.
 artikel
17 International comparisons of ESRD therapy 1999
 2S1 p. S144-S151
8 p.
 artikel
18 Introduction Held, Philip J.
 1997
 2S1 p. S1-S3
3 p.
 artikel
19 Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report Wolfe, Robert A.
 1999
 2S1 p. S1-S3
3 p.
 artikel
20 I. The USRDS and its products 1997
 2S1 p. S21-S39
19 p.
 artikel
21 IV. The USRDS dialysis morbidity and mortality study: Wave 2 1997
 2S1 p. S67-S85
19 p.
 artikel
22 IX. Hospitalization 1997
 2S1 p. S145-S159
15 p.
 artikel
23 K/DOQI Advisory Board Members 2002
 2S1 p. S13-
1 p.
 artikel
24 K/DOQI Clinical Practice Guidelines on Chronic Kidney Disease 2002
 2S1 p. S11-S12
2 p.
 artikel
25 K/DOQI Disclaimer 2002
 2S1 p. IBC-
1 p.
 artikel
26 List of common abbreviations 1997
 2S1 p. S8-S9
2 p.
 artikel
27 List of common abbreviations 1999
 2S1 p. S7-S8
2 p.
 artikel
28 Part 12. Acknowledgements 2002
 2S1 p. S243-S245
3 p.
 artikel
29 Part 10. Appendices 2002
 2S1 p. S223-S237
15 p.
 artikel
30 Part 9. Approach to Chronic Kidney Disease usingthese Guidelines 2002
 2S1 p. S215-S222
8 p.
 artikel
31 Part 6. Association of Level of GFR withComplications in Adults 2002
 2S1 p. S111-S169
59 p.
 artikel
32 Part 2. Background 2002
 2S1 p. S32-S36
5 p.
 artikel
33 Part 3. Chronic Kidney Disease as a PublicHealth Problem 2002
 2S1 p. S37-S45
9 p.
 artikel
34 Part 4. Definition and Classification of Stagesof Chronic Kidney Disease 2002
 2S1 p. S46-S75
30 p.
 artikel
35 Part 5. Evaluation of Laboratory Measurementsfor Clinical Assessment of Kidney Disease 2002
 2S1 p. S76-S110
35 p.
 artikel
36 Part 1. Executive Summary 2002
 2S1 p. S17-S31
15 p.
 artikel
37 Part 8. Recommendations for ClinicalPerformance Measures 2002
 2S1 p. S213-S214
2 p.
 artikel
38 Part 7. Stratification of Risk for Progression of Kidney Disease and Development of Cardiovascular Disease 2002
 2S1 p. S170-S212
43 p.
 artikel
39 Part 11. Work Group Members 2002
 2S1 p. S238-S242
5 p.
 artikel
40 Patient characteristics at the start of ESRD: Data from the HCFA Medical Evidence Form 1999
 2S1 p. S63-S73
11 p.
 artikel
41 Patient mortality and survival 1999
 2S1 p. S74-S86
13 p.
 artikel
42 Pediatric End-Stage renal disease 1999
 2S1 p. S102-S113
12 p.
 artikel
43 Renal transplantation: Access and outcomes 1999
 2S1 p. S95-S101
7 p.
 artikel
44 Tables 2002
 2S1 p. S1-S4
4 p.
 artikel
45 The economic cost of ESRD and medicare spending for alternative modalities of treatment 1999
 2S1 p. S124-S139
16 p.
 artikel
46 The USRDS and its products 1999
 2S1 p. S20-S39
20 p.
 artikel
47 Treatment modalities for ESRD patients 1999
 2S1 p. S51-S62
12 p.
 artikel
48 VI. causes of death 1997
 2S1 p. S107-S117
11 p.
 artikel
49 VIII. Pediatric end-stage renal disease 1997
 2S1 p. S128-S144
17 p.
 artikel
50 VII. Renal transplantation: Access and outcomes 1997
 2S1 p. S118-S127
10 p.
 artikel
51 V. Patient mortality and survival 1997
 2S1 p. S86-S106
21 p.
 artikel
52 Who's who in the usrds 1997
 2S1 p. S5-S7
3 p.
 artikel
53 Who's who in the USRDS 1999
 2S1 p. S4-S6
3 p.
 artikel
54 XI. Annual facility survey of providers of ESRD therapy 1997
 2S1 p. S178-S186
9 p.
 artikel
55 XIII. Analytical methods 1997
 2S1 p. S195-S213
19 p.
 artikel
56 XII. International comparisons of ESRD therapy 1997
 2S1 p. S187-S194
8 p.
 artikel
57 X. The economic cost of ESRD, vascular access procedures, and medicare spending for alternative modalities of treatment 1997
 2S1 p. S160-S177
18 p.
 artikel
                             57 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland